Efficacy of xanthine oxidase inhibitor for chronic kidney disease patients with hyperuricemia

被引：0
|
作者：
Hiroshi Matsuo
Eiji Ishikawa
Hirofumi Machida
Yasuhide Mizutani
Akiko Tanoue
Takahiro Ohnishi
Tomohiro Murata
Shinya Okamoto
Toru Ogura
Yuki Nishimura
Hiroo Ito
Masashi Yasutomi
Kan Katayama
Shinsuke Nomura
Masaaki Ito
机构：
[1] Suzuka Kaisei Hospital,Department of Kidney Center
[2] Mie University Graduate School of Medicine,Department of Cardiology and Nephrology
[3] Takeuchi Hospital,Department of Internal Medicine
[4] Yokkaichi Hazu Medical Center,Department of Nephrology
[5] Murase Hospital,Department of Internal Medicine
[6] Ise Red Cross Hospital,Department of Nephrology
[7] Mie University Hospital,Clinical Research Support Center
[8] Nabari City Hospital,Department of Internal Medicine
[9] Kuwana City Medical Center,Department of Nephrology
来源：
Clinical and Experimental Nephrology | 2020年 / 24卷
关键词：
Chronic kidney disease; Febuxostat; Hyperuricemia; Topiroxostat; Urinary protein; Xanthine oxidase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：307 / 313
页数：6
相关论文
共 50 条
  • [21] Hyperuricemia and xanthine oxidase in preeclampsia, revisited
    Many, A
    Hubel, CA
    Roberts, JM
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (01) : 288 - 291
  • [22] POSSIBILITIES OF RENOPROTECTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERURICEMIA
    Khimion, L.
    Naishtetik, I.
    Burianov, O.
    Rotova, S.
    Smiyan, S.
    Danyliuk, S.
    Trofanchuk, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1652 - 1652
  • [23] Clinical classification of hyperuricemia in patients with chronic kidney disease
    Fengqin Li
    Hui Guo
    Jianan Zou
    Chensheng Fu
    Song Liu
    Jing Xiao
    Zhibin Ye
    International Urology and Nephrology, 2021, 53 : 1665 - 1674
  • [24] Clinical classification of hyperuricemia in patients with chronic kidney disease
    Li, Fengqin
    Guo, Hui
    Zou, Jianan
    Fu, Chensheng
    Liu, Song
    Xiao, Jing
    Ye, Zhibin
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (08) : 1665 - 1674
  • [25] Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
    Akimoto, Tetsu
    Morishita, Yoshiyuki
    Ito, Chiharu
    Iimura, Osamu
    Tsunematsu, Sadao
    Watanabe, Yuko
    Kusano, Eiji
    Nagata, Daisuke
    DRUG TARGET INSIGHTS, 2014, 8 : 39 - 43
  • [26] Uric-Acid Lowering Treatment by a Xanthine Oxidase Inhibitor Improved the Diastolic Function in Patients with Hyperuricemia
    Ogino, Kazuhide
    Kinugasa, Yoshiharu
    Kato, Masahiko
    Yamamoto, Kazuhiro
    Hamada, Toshihiro
    Hisatome, Ichiro
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S26 - S26
  • [27] Febuxostat: A Selective Xanthine-Oxidase/Xanthine-Dehydrogenase Inhibitor for the Management of Hyperuricemia in Adults With Gout
    Ernst, Michael E.
    Fravel, Michelle A.
    CLINICAL THERAPEUTICS, 2009, 31 (11) : 2503 - 2518
  • [28] Natural Xanthine Oxidase Inhibitor 5-O-Caffeoylshikimic Acid Ameliorates Kidney Injury Caused by Hyperuricemia in Mice
    Zhang, Dong
    Zhao, Mojiao
    Li, Yumei
    Zhang, Dafang
    Yang, Yong
    Li, Lijing
    MOLECULES, 2021, 26 (23):
  • [29] Safety and Efficacy of Benzbromarone and Febuxostat in Hyperuricemia Patients with Chronic Kidney Disease: A Prospective Pilot Study
    Haibo Yu
    Xinying Liu
    Yaxiang Song
    Jiafen Cheng
    Hui Bao
    Ling Qin
    Xuan Zhou
    Ling Wang
    Ai Peng
    Clinical and Experimental Nephrology, 2018, 22 : 1324 - 1330
  • [30] Safety and Efficacy of Benzbromarone and Febuxostat in Hyperuricemia Patients with Chronic Kidney Disease: A Prospective Pilot Study
    Yu, Haibo
    Liu, Xinying
    Song, Yaxiang
    Cheng, Jiafen
    Bao, Hui
    Qin, Ling
    Zhou, Xuan
    Wang, Ling
    Peng, Ai
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (06) : 1324 - 1330
12345